BBA
HRTX icon

Baker Bros. Advisors’s Heron Therapeutics HRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,131,678
Closed -$8.38M 93
2023
Q3
$8.38M Hold
8,131,678
0.05% 50
2023
Q2
$9.43M Hold
8,131,678
0.05% 59
2023
Q1
$12.3M Hold
8,131,678
0.07% 47
2022
Q4
$20.3M Hold
8,131,678
0.12% 41
2022
Q3
$34.3M Hold
8,131,678
0.22% 33
2022
Q2
$22.7M Hold
8,131,678
0.13% 45
2022
Q1
$46.5M Hold
8,131,678
0.27% 30
2021
Q4
$74.2M Hold
8,131,678
0.36% 24
2021
Q3
$86.9M Hold
8,131,678
0.38% 21
2021
Q2
$126M Buy
8,131,678
+2,136,974
+36% +$33.2M 0.55% 17
2021
Q1
$97.2M Hold
5,994,704
0.42% 23
2020
Q4
$127M Hold
5,994,704
0.48% 17
2020
Q3
$88.8M Sell
5,994,704
-23,400
-0.4% -$347K 0.36% 18
2020
Q2
$88.5M Hold
6,018,104
0.39% 21
2020
Q1
$70.7M Hold
6,018,104
0.44% 20
2019
Q4
$141M Hold
6,018,104
0.75% 15
2019
Q3
$111M Hold
6,018,104
0.76% 14
2019
Q2
$112M Buy
6,018,104
+1,000,000
+20% +$18.6M 0.76% 15
2019
Q1
$123M Hold
5,018,104
0.79% 14
2018
Q4
$130M Sell
5,018,104
-7,194
-0.1% -$187K 1.07% 11
2018
Q3
$159M Hold
5,025,298
1.05% 11
2018
Q2
$195M Hold
5,025,298
1.47% 9
2018
Q1
$139M Buy
5,025,298
+1,964,657
+64% +$54.2M 1.18% 11
2017
Q4
$55.4M Buy
3,060,641
+272,649
+10% +$4.93M 0.48% 24
2017
Q3
$45M Buy
2,787,992
+4,423
+0.2% +$71.4K 0.37% 21
2017
Q2
$38.6M Hold
2,783,569
0.34% 21
2017
Q1
$41.8M Buy
2,783,569
+400,000
+17% +$6M 0.34% 22
2016
Q4
$31.2M Sell
2,383,569
-473,681
-17% -$6.21M 0.31% 25
2016
Q3
$49.2M Hold
2,857,250
0.45% 23
2016
Q2
$51.6M Sell
2,857,250
-50,534
-2% -$912K 0.54% 19
2016
Q1
$55.2M Hold
2,907,784
0.58% 24
2015
Q4
$77.6M Hold
2,907,784
0.64% 23
2015
Q3
$71M Buy
2,907,784
+100,000
+4% +$2.44M 0.66% 19
2015
Q2
$87.5M Buy
2,807,784
+200,000
+8% +$6.23M 0.77% 19
2015
Q1
$37.9M Hold
2,607,784
0.32% 29
2014
Q4
$26.2M Hold
2,607,784
0.27% 35
2014
Q3
$21.7M Hold
2,607,784
0.27% 35
2014
Q2
$32.1M Buy
2,607,784
+440,000
+20% +$5.42M 0.39% 31
2014
Q1
$30.2M Buy
+2,167,784
New +$30.2M 0.38% 34